Advertisement
Advertisement

PTGX

PTGX logo

Protagonist Therapeutics, Inc

84.49
USD
Sponsored
+3.79
+4.70%
Feb 06, 15:59 UTC -5
Closed
exchange

Pre-Market

84.16

-0.33
-0.39%

Protagonist Therapeutics, Inc Financial Snapshot

Market Cap
5.26B
Beta
2.26
Earnings Per Share (EPS)
0.62
Price-to-Book (P/B) Ratio
7.81
Operating Margin
21.94%
Total Debt/Equity (D/E)
0.00%
P/E Ratio
130.11
Return on Equity (ROE)
6.86%
Current Ratio
13.05%
Free Cash Flow
93.20M

Earnings Chart

Advertisement